{
"id":"mk19_a_np_q032",
"number":32,
"bookId":"np",
"correctAnswer":"B",
"title":"Question 32",
"stimulus":[
{
"type":"p",
"hlId":"32c88e",
"children":[
"A 46-year-old man is evaluated for confirmed primary hypertension. The patient is asymptomatic and takes no medications. He is a current smoker with a 20-pack-year history. Family history is significant for hypertension in his mother and father; his father had a stroke at age 55 years."
]
},
{
"type":"p",
"hlId":"698fbc",
"children":[
"On physical examination, blood pressure is 154/96 mm Hg in both arms, pulse rate is 74/min, and respiration rate is 18/min. BMI is 30. The remainder of the examination is normal."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"340fba",
"class":"cell text l",
"children":[
"Fasting lipid profile:"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"182194",
"class":"cell text li",
"children":[
"Total cholesterol"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"9bfc77",
"class":"cell text l",
"children":[
"220 mg/dL (5.7 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"0c2f10",
"class":"cell text li",
"children":[
"LDL cholesterol"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"f34cbd",
"class":"cell text l",
"children":[
"160 mg/dL (4.1 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"8a43cb",
"class":"cell text li",
"children":[
"HDL cholesterol"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"b1b995",
"class":"cell text l",
"children":[
"48 mg/dL (1.2 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"23f624",
"class":"cell text l",
"children":[
"1.0 mg/dL (88.4 µmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"06bcde",
"class":"cell text l",
"children":[
"Electrolytes"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"960b44",
"class":"cell text l",
"children":[
"Normal"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"d42e3c",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Glucose, plasma",
"children":[
"Glucose, fasting"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"5f8c08",
"class":"cell text l",
"children":[
"80 mg/dL (4.4 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"747c2a",
"class":"cell text l",
"children":[
"Urinalysis"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"ec7a86",
"class":"cell text l",
"children":[
"No protein, erythrocytes, or leukocytes"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"bc1f37",
"children":[
"A 12-lead ECG is normal."
]
},
{
"type":"p",
"hlId":"a58740",
"children":[
"The patient is instructed in lifestyle modifications, including smoking cessation, exercise, and a low sodium diet. Moderate-intensity atorvastatin is initiated."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"907369",
"children":[
"Which of the following is the most appropriate additional therapy?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Amlodipine"
}
},
{
"letter":"B",
"text":{
"__html":"Amlodipine-valsartan"
}
},
{
"letter":"C",
"text":{
"__html":"Chlorthalidone"
}
},
{
"letter":"D",
"text":{
"__html":"Valsartan"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"2e5eff",
"children":[
"A blood pressure <130/80 mm Hg is recommended for adults with hypertension and cardiovascular disease or a 10-year atherosclerotic cardiovascular disease event risk ≥10%."
]
},
{
"type":"keypoint",
"hlId":"ecb044",
"children":[
"Combination therapy with two first-line antihypertensive medications of different classes is recommended for adults with stage 2 hypertension and an average blood pressure (BP) of >20/10 mm Hg above BP target."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"ca6c86",
"children":[
"The most appropriate additional therapy is amlodipine-valsartan (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). This patient has stage 2 hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg). For patients with stage 2 hypertension with or without cardiovascular risk or disease, pharmacologic management in addition to therapeutic lifestyle interventions is recommended. The 2017 American College of Cardiology/American Heart Association blood pressure (BP) guideline recommends combination therapy with two first-line antihypertensive drugs of different classes for adults with stage 2 hypertension and an average BP that is 20/10 mm Hg above their BP target. Based on the presence of hypertension, dyslipidemia, and cigarette smoking, this patient has a calculated 10-year atherosclerotic cardiovascular disease (ASCVD) event risk of 10%. The target BP for patients with established cardiovascular disease or for patients with an estimated ASCVD event risk ≥10% is 130/80 mm Hg. This patient has an elevated 10-year ASCVD event risk and his BP is >20/10 mm Hg above target; therefore, combination drug therapy is indicated. To maximize adherence, using a fixed-dose combination agent may be more effective than adding two separate antihypertensive agents."
]
},
{
"type":"p",
"hlId":"c12740",
"children":[
"Starting chlorthalidone, amlodipine, or valsartan (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Options A, C, D"
]
},
") as single-agent therapy would each be appropriate as first-line therapy for patients with stage 1 hypertension (systolic BP of 130-139 mm Hg or diastolic BP of 80–89 mm Hg). Combination therapy is recommended for patients with stage 2 hypertension and an average BP that is 20/10 mm Hg above their BP target."
]
}
],
"relatedSection":"mk19_a_np_s4_7_2_3_4",
"objective":{
"__html":"Treat stage 2 hypertension with combination drug therapy."
},
"references":[
[
"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29146535",
"target":"_blank"
},
"children":[
"PMID: 29146535"
]
}
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":14,
"B":34,
"C":40,
"D":12,
"E":0
},
"hlIds":[
"32c88e",
"698fbc",
"a462a3",
"340fba",
"d41d8c",
"182194",
"9bfc77",
"0c2f10",
"f34cbd",
"8a43cb",
"b1b995",
"f461b2",
"23f624",
"06bcde",
"960b44",
"d42e3c",
"5f8c08",
"747c2a",
"ec7a86",
"bc1f37",
"a58740",
"907369",
"2e5eff",
"ecb044",
"ca6c86",
"c12740"
]
}